This item requires a subscription toJournal of Clinical Oncology Online.
Full Text
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
Vredenburgh et al. J Clin Oncol.2007;
25:
4722-4729
To view this item, select one of the options below:
Sign In
Athens Users
Sign in via Athens: Access is available using your Athens username and password. Contact your library if you do not have an Athens username and password.